Shizuoka, Japan

Kazuyoshi Marubayashi

This inventor holds 3 USPTO granted patents. Top assignees: Botanix Sb, Inc., Brickell Biotech, Inc., Kaken Pharmaceutical Company, Ltd.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyoshi Marubayashi. Retrieved from https://idiyas.com/inventor/kazuyoshi-marubayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuyoshi Marubayashi: Innovator in Sofpironium Bromide Patents

Introduction

Kazuyoshi Marubayashi, an accomplished inventor based in Shizuoka, Japan, has made significant strides in the field of pharmaceutical innovation. With a total of two patents to his name, Marubayashi has focused his efforts on developing stable crystalline forms of sofpironium bromide, a compound relevant to the creation of effective medicaments.

Latest Patents

Marubayashi's latest patents revolve around various crystalline forms of sofpironium bromide. The first patent describes a cocrystal comprising the 1'R-diastereomer and the 1'S-diastereomer of sofpironium bromide in a specific ratio of 1:3 (Form CO). This patent details additional formulations, including a crystal mixture (Form B) that maintains the superior stability and non-hygroscopic properties of Form CO. These properties make them highly suitable as raw materials for medicaments. Marubayashi's innovative approach ensures the pharmaceutical industry can benefit from more stable and efficient formulations.

Career Highlights

Kazuyoshi Marubayashi is currently affiliated with Botanix Sb, Inc., where he continues to contribute to groundbreaking research in his field. His expertise in the preparation and stabilization of pharmaceutical compounds distinguishes him as a key figure in the healthcare innovation space. Marubayashi’s work not only enhances drug efficacy but also improves manufacturing processes for stable medical products.

Collaborations

Throughout his career, Marubayashi has collaborated with esteemed colleagues in the field, including Masahito Watanabe and Herbert Robert Brinkman. These collaborations have enabled significant advancements in the formulations of pharmaceutical compounds and have fostered a research environment conducive to innovation.

Conclusion

In summary, Kazuyoshi Marubayashi stands out as a dedicated inventor whose work on sofpironium bromide has the potential to revolutionize the pharmaceutical industry. Through his patents and collaborations, he exemplifies the importance of innovation in the development of effective medicinal products, paving the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…